Adap­tive Biotech­nolo­gies trims hand­ful of jobs as strate­gic re­view nears com­ple­tion

Adap­tive Biotech­nolo­gies, a Seat­tle-based di­ag­nos­tics mak­er and drug dis­cov­ery com­pa­ny, told End­points News it re­cent­ly elim­i­nat­ed 6.7% of its work­force as part of its strate­gic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.